Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Acetaminophen skin reacting warning in draft guidance; supplement ingredient testing exemption option continues; FTC breaks Habitrol from GSK/Novartis JV; NARB stops clock on Mucinex 8-minute claim; kick start for ClickStick; NVC drinks up Blu-Dot; drug claims, GMP problems for Avena Botanicals; Ugam beefs up MusclePharm price monitoring; Nutraceutical International growth trims income; SDC Nutrition on global mission; and Naturally Splendid acquires Full Spectrum technology.
You may also be interested in...
Mucinex Fast-Max Advertising Claim Exceeds Indications In NAD Review
Review was second in two years by the Council of Better Business Bureaus' National Advertising Division of a challenge to Reckitt Benckiser ad claims for its Mucinex cough/cold line made by Procter & Gamble, which markets competing products including Vicks NyQuil and DayQuil brands.
Mucinex Fast-Max Advertising Claim Exceeds Indications In NAD Review
Review was second in two years by the Council of Better Business Bureaus' National Advertising Division of a challenge to Reckitt Benckiser ad claims for its Mucinex cough/cold line made by Procter & Gamble, which markets competing products including Vicks NyQuil and DayQuil brands.
Supplement Firms Confounded By Identity Testing Waiver Process
FDA says it has not received any petitions to request an exemption from the 100% supplement ingredient identity testing requirement. Food and drug attorneys say the hassle of preparing a petition for a waiver outweighs the potential benefits